KLF6 has been reported as a tumor suppressor in prostate cancer [27] and recently a splice variant thereof, KLF6-SV1, was identified as an oncogene in breast cancer with increased expression in breast tumors [28]. This evidence concerns the gene KLF6 and breast cancer.